BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS) will release its Q1 2026 financial results on May 7, 2026 and host a conference call and live webcast at 4:30 PM ET (1:30 PM PT). Management will provide an overview of results and a general business update.

Investors can access the live webcast via the company Investor Relations earnings page. A replay will be posted about two hours after the call and archived for 90 days on the investor website.

News Market Reaction – BLFS

-1.57%

-1.57% Session close to close

In the Apr 24 session, BLFS declined 1.57%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timeline for BioLife Solutions’ Q1 2026 earnings release on May 7, 2026, ...

Analysis

This announcement sets the timeline for BioLife Solutions’ Q1 2026 earnings release on May 7, 2026, with a 4:30pm ET call and a 90-day replay. Historically, similar earnings-date notices produced only modest share moves, while actual results and business updates have driven more meaningful reactions. Investors may watch how Q1 performance tracks against prior 2025 revenue growth and margin trends, plus any commentary on CGT market demand and pipeline execution.

Key Figures

Earnings release date: May 7, 2026 Conference call time: 4:30pm ET (1:30pm PT) Replay availability: 90 days

3 metrics

Earnings release date May 7, 2026 Planned Q1 2026 results announcement

Conference call time 4:30pm ET (1:30pm PT) Scheduled Q1 2026 earnings call

Replay availability 90 days Webcast replay archive duration

Previous Earnings date Reports

1 past event · Latest: Feb 17 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 17	Earnings date notice	Neutral	+0.6%	Scheduled Q4 and full-year 2025 results with post-call replay access.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited tag-specific history: the prior earnings-date notice saw a small positive move of 0.58%, suggesting these scheduling updates have historically had only modest impact.

Recent Company History

Recent BLFS news featured multiple operational and financial milestones. On Feb 17, 2026, the company announced the date and webcast details for reporting Q4 and full-year 2025 results, which coincided with a modest 0.58% gain. Subsequent earnings on Feb 26, 2026 showed growing revenue and margins, and an April INTERPHEX 2026 innovation award highlighted product strength. Today’s Q1 2026 earnings-date announcement fits the pattern of routine scheduling communications.

Key Terms

cell and gene therapy

1 terms

cell and gene therapy medical

"bioproduction products and services for the cell and gene therapy ("CGT") market"

Therapies that use living cells or altered genes to treat or cure disease by repairing, replacing or reprogramming parts of the body; think of it as swapping or reprogramming malfunctioning hardware or software inside the body. Investors watch these treatments closely because they can command high prices and offer one-time or long-lasting benefits, but they also carry big development costs, complex manufacturing and regulatory risks that can cause large swings in a company’s value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOTHELL, Wash., April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first quarter financial results will be released on May 7, 2026. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions

BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2026-financial-results-and-business-update-on-may-7-2026-302752233.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) report Q1 2026 results?

BioLife Solutions will release Q1 2026 financial results on May 7, 2026. According to the company, management will host a conference call and webcast that same day at 4:30 PM ET (1:30 PM PT) to review results and provide a business update.

How can I join the BioLife Solutions (BLFS) May 7, 2026 earnings webcast?

Join the live webcast on the company's Investor Relations earnings page. According to the company, the webcast link is available at the BioLife Solutions earnings page and will stream live at 4:30 PM ET on May 7, 2026.

What phone numbers host the BioLife Solutions (BLFS) conference call on May 7, 2026?

Dial toll-free 1-833-630-0431 for U.S. callers or 1-412-317-1808 for international callers. According to the company, these numbers provide access to the conference call at 4:30 PM ET on May 7, 2026.

Will a replay of the BioLife Solutions (BLFS) May 7, 2026 call be available?

Yes. According to the company, a webcast replay will be available about two hours after the call and archived for 90 days on the investor website. Investors can access the replay via the archived webcast page.

What will BioLife Solutions (BLFS) management cover during the May 7, 2026 call?

Management will provide an overview of the company's financial results and a general business update. According to the company, the call is intended to summarize Q1 2026 performance and key business developments for investors.

Where is the BioLife Solutions (BLFS) webcast archived after the May 7, 2026 call?

The replay will be archived on the company's investor site at investors.biolifesolutions.com for 90 days. According to the company, the archived webcast will be posted approximately two hours after the live call on May 7, 2026.